MONTECUCCO, CARLOMAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 24.448
AS - Asia 18.967
EU - Europa 13.809
SA - Sud America 2.529
AF - Africa 647
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 15
Totale 60.447
Nazione #
US - Stati Uniti d'America 23.911
CN - Cina 8.938
SG - Singapore 4.301
IE - Irlanda 3.262
HK - Hong Kong 2.048
BR - Brasile 1.896
VN - Vietnam 1.763
DE - Germania 1.746
UA - Ucraina 1.711
RU - Federazione Russa 1.575
FI - Finlandia 1.483
IT - Italia 903
FR - Francia 887
SE - Svezia 865
GB - Regno Unito 671
IN - India 404
ZA - Sudafrica 337
BD - Bangladesh 315
CA - Canada 295
AR - Argentina 233
IQ - Iraq 156
JP - Giappone 153
TR - Turchia 124
MX - Messico 123
AT - Austria 107
EC - Ecuador 103
CO - Colombia 95
PK - Pakistan 92
NL - Olanda 91
PL - Polonia 91
ES - Italia 85
SA - Arabia Saudita 79
ID - Indonesia 77
BE - Belgio 68
VE - Venezuela 62
MA - Marocco 58
UZ - Uzbekistan 54
MY - Malesia 52
PH - Filippine 52
CZ - Repubblica Ceca 49
TN - Tunisia 44
AE - Emirati Arabi Uniti 43
IR - Iran 41
CL - Cile 39
KE - Kenya 39
EG - Egitto 38
LT - Lituania 36
NP - Nepal 34
PY - Paraguay 34
JO - Giordania 28
PE - Perù 27
AU - Australia 25
IL - Israele 25
ET - Etiopia 23
DZ - Algeria 22
AZ - Azerbaigian 21
KZ - Kazakistan 21
RO - Romania 21
SN - Senegal 21
CR - Costa Rica 20
MU - Mauritius 19
AL - Albania 18
DO - Repubblica Dominicana 18
UY - Uruguay 18
BO - Bolivia 17
OM - Oman 16
PA - Panama 14
TH - Thailandia 14
KR - Corea 13
LV - Lettonia 13
DK - Danimarca 12
HU - Ungheria 12
KG - Kirghizistan 12
LB - Libano 12
PS - Palestinian Territory 12
JM - Giamaica 11
SY - Repubblica araba siriana 11
TT - Trinidad e Tobago 11
BG - Bulgaria 10
EU - Europa 10
HN - Honduras 10
NI - Nicaragua 10
RS - Serbia 10
GR - Grecia 9
SK - Slovacchia (Repubblica Slovacca) 9
BY - Bielorussia 8
KW - Kuwait 8
MK - Macedonia 8
NG - Nigeria 8
PT - Portogallo 8
CH - Svizzera 7
GE - Georgia 7
HR - Croazia 7
LK - Sri Lanka 7
MD - Moldavia 7
NO - Norvegia 7
NZ - Nuova Zelanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AO - Angola 4
BA - Bosnia-Erzegovina 4
Totale 60.337
Città #
Dublin 3.241
Chandler 3.007
San Jose 2.795
Jacksonville 2.266
Ashburn 2.215
Singapore 2.109
Hong Kong 2.004
Nanjing 1.841
Dallas 1.685
Beijing 1.336
Boardman 1.005
Nanchang 758
Princeton 720
Lawrence 662
Lauterbourg 648
Wilmington 621
Ho Chi Minh City 611
Helsinki 593
Los Angeles 579
Changsha 555
Shenyang 553
Hebei 539
Medford 471
Munich 436
Jiaxing 426
New York 417
Hanoi 415
Council Bluffs 344
Hangzhou 322
Tianjin 309
Shanghai 285
Johannesburg 283
Redondo Beach 282
Moscow 280
Ann Arbor 276
Buffalo 263
Milan 227
São Paulo 172
Houston 159
Orem 152
Woodbridge 146
Turku 144
Pavia 142
Norwalk 132
Tokyo 131
Santa Clara 122
Da Nang 119
Seattle 103
Verona 102
Chicago 101
Toronto 101
Frankfurt am Main 96
Brooklyn 91
Montreal 83
Fairfield 80
London 80
Warsaw 79
Falkenstein 78
Chennai 77
Vienna 75
The Dalles 73
Guangzhou 70
Brussels 68
San Francisco 68
Rio de Janeiro 65
Denver 64
Haiphong 61
Atlanta 58
Zhengzhou 58
Jinan 56
Stockholm 56
Nuremberg 55
Washington 53
Baghdad 52
Boston 51
Pune 49
Manchester 48
Ningbo 48
Amsterdam 46
Belo Horizonte 46
Tashkent 46
Phoenix 45
Poplar 44
Columbus 43
Brasília 41
Mexico City 41
Ankara 39
Porto Alegre 39
Quito 37
Des Moines 35
Piscataway 35
Dhaka 34
Mumbai 34
Kunming 33
Biên Hòa 32
New Delhi 32
Jeddah 31
Lahore 31
Curitiba 30
Nairobi 30
Totale 39.821
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 263
Ultrasonographic evaluation of entheses in patients with spondyloarthritis: a systematic literature review 195
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 169
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 161
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 157
[Italian Society of Rheumatology (SIR) recommendations for performing arthrocentesis.] 155
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 155
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis. 153
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 152
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 150
Milwaukee shoulder syndrome(artropatia destruente apatite-associata):aspetti terapeutici 147
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 147
B cells in rheumatoid arthritis. 146
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 143
Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two steps strategy using a self administered questionnaire and autoantibody testing. 141
Antinuclear antibodies in systemic sclerosis 140
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers 140
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 139
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 139
A case of adult onset Still's disease treated with infliximab - Reply 139
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 138
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: Comparison of two cohorts treated according to different treat to target protocols 138
Disease-related malnutrition in systemic sclerosis: Evidences and implications 137
Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis 137
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 136
DMARDS and infections in rheumatoid arthritis 135
[Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2)]. 135
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis 134
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 133
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 132
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 132
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 131
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 131
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 131
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 130
A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. 129
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 129
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 129
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. 128
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 128
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 128
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 128
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 128
Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism 127
Clinical, genetic amd immunologic analysis of a family affected by Ozena. 126
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 126
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 126
A Flow Cytometric Study of the Propidium Iodide Staining Kinetics of Human-leukocytes and Its Relationship With Chromatin Structure 125
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 124
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 124
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 124
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 124
Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. 123
Multidisciplinary model for hospital-territory integrated management of patient with bone fragility: Primary and secondary prevention of fractures according to severity and complexity 123
Shrinking lung syndrome in sistemic sclerosis 123
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 121
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis 120
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 120
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. 120
Diffuse skin reaction after changing the etanercept formulation 120
B cells in rheumatoid arthritis. 120
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 120
Localized and systemic forms of scleroderma in adults and children. 119
Chemochine linfoidi nella sinovite reumatoide 119
Antibodies to cyclic citrullinated peptides in psoriatic arthritis. 119
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 119
The role of Trimethoprim/sulfametoxazole in reducing relapses and risk of infec-tions in ANCA-associated vasculitis: a meta-analysis 119
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort 119
[Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy]. 118
Analysis of Human Myeloma Cell-population Kinetics 118
Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases 118
Tocilizumab for treatment of severe covid-19 patients: Preliminary results from smatteo covid19 registry (smacore) 118
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 118
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs 118
TNFalpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects. 117
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 117
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study). 117
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 117
Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis 117
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 117
Interessamento cutaneo nella dermatomiosite 116
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 116
A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome 115
Clinical, genetic and immunologic analysis of a family affected by ozena 115
Association between anti-dsDNA titre increase and thymoma relapse 114
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects]. 114
Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal 113
Lifestyle and dietary habits of patients with gout followed in rheumatology settings 113
Mature antigen-experienced helper T cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of rheumatoid joint 113
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 113
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment. 112
Influenza may influence rheumatoid arthritis 112
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 112
Pulmonary nocardiosis in a patient affected by anti-MDA5-positive amyopathic dermatomyositis under immunosuppressive therapy 112
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 112
Clinical and experimental evidences of Italian viper venom neurotoxicity. 111
A genetic variation located in the promoter region of the UPAR(CD87) gene is associated with the vascular complications of systemic sclerosis. 111
Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series 111
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 111
Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. 111
Totale 12.885
Categoria #
all - tutte 273.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 273.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 0 0 0 0 0 0 150
2021/20222.729 49 18 71 28 60 93 58 178 148 60 441 1.525
2022/20239.143 1.111 618 87 609 945 914 8 506 3.841 61 241 202
2023/20243.418 408 732 131 238 309 858 105 221 36 119 101 160
2024/20259.508 230 786 167 251 116 460 491 746 2.327 356 1.048 2.530
2025/202622.023 1.636 1.591 2.559 2.172 2.456 946 4.454 1.006 1.918 1.625 1.018 642
Totale 61.607